OPUS 4 Latest Documents RSS Feed Latest documents http://publikationen.ub.uni-frankfurt.de/index/index/ Sun, 20 Sep 2009 11:41:14 +0200 Sun, 20 Sep 2009 11:41:14 +0200 Virological and immunological response to three boosted protease inhibitor regimens http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7054 Poster presentation: Purpose of the study To compare the virological, immunological and clinical response to three boosted double protease inhibitor (PI) regimens of saquinavir and ritonavir in combination with lopinavir (LOPSAQ), atazanavir (ATSAQ) or fosamprenavir (FOSAQ) without reverse transcriptase inhibitors (RTI) in HIV-positive patients with limited RTI treatment options. ... Christian Baumgardt; Christoph Stephan; Annette Elisabeth Haberl; Hans-Reinhard Brodt; Martin Stürmer; Stefan Klauke; Peter Gute; Markus Bickel; Pavel Khaykin; Nils von Hentig; Schlomo Staszewski article http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7054 Sun, 20 Sep 2009 11:41:14 +0200 Lipometabolic side-effects of three ritonavir-boosted doubleprotease inhibitor regimens without reverse transcriptase inhibitors http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7052 Poster presentation: Purpose of the study To compare the lipometabolic profiles of three double-boosted protease inhibitor (PI) regimens at standard dose, containing saquinavir and ritonavir in combination with lopinavir (LOPSAQ), atazanavir (ATSAQ) or fosamprenavir (FOSAQ) in HIV-positive patients, treated without reverse transcriptase inhibitors (RTI). ... Annette Wendig; Christoph Stephan; Pavel Khaykin; Markus Bickel; Tessa Lennemann; Gaby Knecht; Thomas Lutz; Nils von Hentig; Schlomo Staszewski article http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7052 Sun, 20 Sep 2009 11:15:47 +0200